Thank you for your interest in the RESTORE open-label study of investigational FT218 (once-nightly sodium oxybate) for patients with narcolepsy.

Please tell us who you are:
Avadel also uses third-party cookies to improve your experience and our services, and to analyze the use of our website. If you continue browsing, we take that to mean that you accept their use. You have the ability to opt out of these cookies, as well as request, delete, or update your information here. For additional information, please review our Terms and Conditions.